Symbol="KRTX"
AssetType="Common Stock"
Name="Karuna Therapeutics Inc"
Description="Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts."
CIK="1771917"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="33 ARCH STREET, SUITE 3110, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="7678641000"
EBITDA="-338368992"
PERatio="None"
PEGRatio="None"
BookValue="39.79"
DividendPerShare="0"
DividendYield="0"
EPS="-9.43"
RevenuePerShareTTM="0.343"
ProfitMargin="0"
OperatingMarginTTM="-30.07"
ReturnOnAssetsTTM="-0.213"
ReturnOnEquityTTM="-0.325"
RevenueTTM="11291000"
GrossProfitTTM="10637000"
DilutedEPSTTM="-9.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.857"
AnalystTargetPrice="277.24"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.38"
PriceToBookRatio="5.94"
EVToRevenue="138.07"
EVToEBITDA="-25.22"
Beta="1.031"
num_52WeekHigh="278.25"
num_52WeekLow="122.59"
num_50DayMovingAverage="222.9"
num_200DayMovingAverage="206.83"
SharesOutstanding="37444000"
DividendDate="None"
ExDividendDate="None"
symbol="KRTX"
open="204.57"
high="206.05"
low="201.44"
price="203.11"
volume="197346.00"
latest_trading_day="2023-07-24"
previous_close="205.07"
change="-1.96"
change_percent="-0.9558%"
aroon_positive_momentum_days="56"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="421191"
Change_recent_avg="-0.13"
Delta_recent_avg="7.25"
Variance_recent_avg="3.63"
Change_ratio_recent_avg="-0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0045.jpeg"
image_negative_thumbnail_id_2="1155"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0189.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="662"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
